Novai Ltd
Research and experimental development on biotechnology · Reading
ActiveUnited KingdomIncorporated 2020Private Limited Company
Financial position
Accounts to 2026-03-31 · GBP · Company accounts
Net assets
£324,616
Cash
£255,888
Turnover
—
Profit / loss
—
Current assets
£1,022,279
Creditors < 1 year
£2,281,230
Equity
—
Average employees
11
Balance-sheet trend
GBP · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
| Reported figures | 2026-03-31Company | 2025-03-31Company | 2024-03-31Company | 2023-03-31 | 2022-03-31 | 2021-02-28 |
|---|---|---|---|---|---|---|
| Balance sheet | ||||||
| Net assets | £324,616 | £111,766 | £698,668 | £390,219 | £451,227 | £727,013 |
| Assets | ||||||
| Fixed assets | £1,746,067 | £2,030,451 | £2,144,736 | £1,584,143 | £599,345 | — |
| Intangible assets | £1,693,316 | £1,958,876 | £1,881,462 | £873,515 | — | — |
| Property, plant & equipment | £52,751 | £71,575 | £263,274 | £710,628 | £599,345 | £12,836 |
| Current assets | £1,022,279 | £1,018,841 | £1,569,304 | £1,874,051 | £2,548,476 | £1,963,477 |
| Cash at bank | £255,888 | £38,081 | £22,238 | £237,596 | £1,216,115 | £801,503 |
| Stock | £722,937 | £787,265 | £795,924 | £799,125 | £877,400 | £908,896 |
| Liabilities | ||||||
| Creditors within one year | £2,281,230 | £2,778,152 | £2,794,018 | £3,045,341 | £2,664,253 | £882,192 |
| Creditors after one year | £162,500 | £159,374 | £221,354 | £22,634 | £32,341 | £367,108 |
| Net current assets | −£1,258,951 | −£1,759,311 | −£1,224,714 | −£1,171,290 | −£115,777 | £1,081,285 |
| Assets less current liabilities | £487,116 | £271,140 | £920,022 | £412,853 | £483,568 | £1,094,121 |
| People & pay | ||||||
| Average employees | 11 | 14 | 18 | 18 | 17 | 7 |
| Source evidence | View filing | View filing | View filing | View filing | View filing | View filing |
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
1 outstanding chargesAll Assets · created 2023-06-30
—
Outstanding